| Primary |
| Asthma |
24.7% |
| Emphysema |
11.8% |
| Hypertension |
11.1% |
| Chronic Obstructive Pulmonary Disease |
11.0% |
| Dyspnoea |
10.1% |
| Bronchitis |
7.3% |
| Cardiac Disorder |
5.0% |
| Blood Pressure |
2.7% |
| Diabetes Mellitus |
2.5% |
| Lung Disorder |
1.9% |
| Abdominal Discomfort |
1.7% |
| Blood Cholesterol |
1.4% |
| Diuretic Therapy |
1.4% |
| Sleep Disorder |
1.3% |
| Anticoagulant Therapy |
1.0% |
| Depression |
1.0% |
| Gastritis |
1.0% |
| Productive Cough |
1.0% |
| Arrhythmia |
0.9% |
| Blood Cholesterol Increased |
0.9% |
|
| Death |
19.3% |
| Dyspnoea |
15.2% |
| Malaise |
6.4% |
| Pneumonia |
6.4% |
| Asthma |
6.1% |
| Emphysema |
4.4% |
| Lung Disorder |
4.4% |
| Cough |
4.1% |
| Fatigue |
3.4% |
| Hallucination |
3.4% |
| Cerebrovascular Accident |
3.0% |
| Diabetes Mellitus |
3.0% |
| Hypertension |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Drug Ineffective |
2.7% |
| Lung Neoplasm Malignant |
2.7% |
| Wrong Technique In Drug Usage Process |
2.7% |
| Asthenia |
2.4% |
| Bronchitis |
2.4% |
| Tachycardia |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
30.4% |
| Asthma |
12.8% |
| Chronic Obstructive Pulmonary Disease |
10.9% |
| Hypertension |
10.2% |
| Atrial Fibrillation |
6.7% |
| Emphysema |
4.3% |
| Dyspnoea |
2.7% |
| Bronchitis |
2.6% |
| Cardiac Disorder |
2.5% |
| Nervousness |
2.5% |
| Malignant Melanoma |
1.9% |
| Oedema Peripheral |
1.6% |
| Arrhythmia |
1.5% |
| Diabetes Mellitus |
1.5% |
| Anxiety |
1.4% |
| Bone Disorder |
1.4% |
| Gastritis |
1.4% |
| Cardiac Failure |
1.3% |
| Abdominal Pain Upper |
1.2% |
| Anger |
1.2% |
|
| Hallucination |
38.9% |
| Dyspnoea |
8.1% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Wrong Technique In Drug Usage Process |
4.7% |
| Death |
4.3% |
| Somnolence |
4.3% |
| Drug Ineffective |
3.8% |
| Cough |
3.4% |
| Fatigue |
3.0% |
| Asthma |
2.6% |
| Hypertension |
2.6% |
| Insomnia |
2.6% |
| Pneumonia |
2.6% |
| Weight Decreased |
2.6% |
| Bronchitis |
2.1% |
| Maternal Exposure During Pregnancy |
2.1% |
| Wheezing |
2.1% |
| Aggression |
1.7% |
| Blood Glucose Increased |
1.7% |
| Drug Exposure During Pregnancy |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.0% |
| Product Used For Unknown Indication |
20.4% |
| Asthma |
15.6% |
| Chronic Obstructive Pulmonary Disease |
11.8% |
| Hypertension |
6.1% |
| Renal Failure Chronic |
3.0% |
| Osteoporosis |
2.8% |
| Non-small Cell Lung Cancer |
2.4% |
| Prophylaxis |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Pain |
1.5% |
| Diabetes Mellitus |
1.3% |
| B-cell Lymphoma |
1.2% |
| Atrial Fibrillation |
1.2% |
| Emphysema |
1.2% |
| Depression |
1.0% |
| Dyspnoea |
1.0% |
| Bronchitis |
0.9% |
| Hiv Infection |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
|
| Dyspnoea |
8.1% |
| Pneumonia |
7.7% |
| Hepatic Enzyme Increased |
7.3% |
| Pain |
6.9% |
| Asthma |
6.6% |
| Vomiting |
6.2% |
| Death |
5.4% |
| Fatigue |
5.4% |
| Weight Decreased |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Palpitations |
4.6% |
| Myocardial Infarction |
4.2% |
| Renal Failure |
4.2% |
| Toxic Shock Syndrome |
4.2% |
| Pruritus |
3.5% |
| Anal Fissure |
3.1% |
| Lung Adenocarcinoma |
3.1% |
| Nausea |
3.1% |
| Rash |
3.1% |
| Respiratory Failure |
3.1% |
|
